The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

The risk of major bleeding event in patients with chronic kidney disease on pentoxifylline treatment

Abstract Patients with chronic kidney diseases (CKD) are often treated with antiplatelets due to aberrant haemostasis. This study aimed to evaluate the bleeding risk with CKD patients undergoing pentoxifylline (PTX) treatment with/without aspirin. In this retrospective study, we used Taiwan’s Nation...

Full description

Bibliographic Details
Main Authors: Jing-Hung Fang, Yi-Chen Chen, Chung-Han Ho, Jui-Yi Chen, Chung-Hsi Hsing, Fu-Wen Liang, Chia-Chun Wu
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-92753-4

Similar Items

Similar Items